Name | FK962 |
Description | FK962 is an somatostatin release enhancer , exerts cognitive-enhancing actions. |
Cell Research | Dissociated, cultured trigeminal ganglion cells, containing neuronal and Schwann cells were cultured for 48 h with or without FK962. Neuronal elongation was evaluated by immunostaining with a neurofilament-specific antibody. Culture with or without GDNF, or with antibody against GDNF, was used to determine the role of GDNF in FK962-induced neurite elongation[1]. |
In vitro | FK962?or GDNF were found to significantly induce neurite elongation. The GDNF antibody significantly inhibited elongation induced by?FK962[1]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 9 mg/mL (34.05 mM)
|
Keywords | FK 962 | FK962 | Alzheimer | somatostatin | inhibit | FK-962 | Inhibitor | cognitive |
Inhibitors Related | 2-Aminoethanethiol | Cyclosomatostatin Acetate | L-803087 | Octreotide Acetate | Cortistatin 14, human, rat acetate | BIM-23190 aceate | L-796,778 | CYN 154806 TFA | (1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid | Cortistatin-14 acetate | Seglitide acetate | Somatostatin acetate |
Related Compound Libraries | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Metabolism Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | NO PAINS Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library |